Select Location
We need your delivery location to continue browsing
Prescription Required
zydus
28 Tablet in Bottle
daclatasvir dihydrochloride
Keep in cold place
Delivering To:
Overview
Dacihep Dihydrochloride tablet is an antiviral medication used for the treatment of chronic (when the infection moves into the long-lasting stage) Hepatitis C virus (HCV). This medication reduces the amount of Hepatitis C virus in the body and helps our immune system fight against infection. It is also used along with other medications for the treatment.
Hepatitis C
Daclatasvir is a direct-acting antiviral (DAA) agent that targets the nonstructural protein 5A (NS5A) and causes a decrease in serum HCV RNA levels. It disrupts HCV replication by specifically inhibiting the critical functions of a nonstructural protein 5A (NS5A) protein in the replication complex. After the oral administration, the effect of this medicine can be observed in 2 hours.
Dacihep Dihydrochloride 60mg tablets may cause certain side effects. If side effects occur after administration or last longer than usual, contact your healthcare professional.
Nausea
Headache
Fatigue
Anemia
Vomiting
Diarrhea
Shortness of breath
Irregular heartbeat
Chest pain
Memory problems
Severe rashes
Fainting
Unusual weakness
Lack of strength
Swelling of the mouth, face, tongue, or throat
Unusual tiredness
Slow heart rate
Take Dacihep Dihydrochloride 60mg tablets as prescribed by your doctor. Do not stop or skip your regular dosing schedule.
In case of an overdose, the doctor will provide emergency medical treatment.
Alcohol
unsafe
It is advisable not to consume alcohol while taking this medicine.
Pregnancy
consult your doctor
Do not take Dacihep Dihydrochloride 60mg tablets without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
caution
Do not take Dacihep Dihydrochloride 60mg tablets without a doctor's consultation in case of kidney problems.
Liver
caution
Share your medical history with the doctor in case of liver disease before taking this medicine.
It is advisable not to miss a dose. If you miss a scheduled dose of this medicine, contact your doctor immediately.
Dacihep (Daclatasvir) tablet is an antiviral medication used for the treatment of chronic (when the infection moves into the long-lasting stage) Hepatitis C virus (HCV).
Take this medicine as prescribed by your doctor.
Some common side effects are:- anemia, irregular heartbeat, insomnia, shortness of breath, lack of strength, dizziness, etc.
This medication reduces the amount of Hepatitis C virus in the body and helps our immune system fight against infection.
This medicine is not recommended for breastfeeding unless it is necessary.
zydus
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.